Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma-Reference-Cited by-同舟云学术

Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma

Published:2024-08-08 Issue:1 Volume:148 Page:
ISSN:1432-0533
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Maas Sybren L. N.,Hielscher Thomas,Sievers Philipp,Hovestadt Volker,Suwala Abigail K.,Acker Till,Weller Michael,Preusser Matthias,Herold-Mende Christel,Wick Wolfgang,von Deimling Andreas,Berghaus Natalie,Sahm Felix^ORCID

Funder

Universitätsklinikum Heidelberg

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00401-024-02777-z.pdf

Reference11 articles.

1. Bello MJ, Pestaña A, Rey JA, De Campos JM, Kusak ME, Vaquero J et al (1994) Allelic loss at 1 p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9:296–298. https://doi.org/10.1002/gcc.2870090411

2. Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V et al (2021) A molecularly integrated grade for meningioma. Neuro Oncol 24:796–808. https://doi.org/10.1093/neuonc/noab213

3. Hielscher T, Sill M, Sievers P, Stichel D, Brandner S, Jones DTW et al (2022) Clinical implementation of integrated molecular-morphologic risk prediction for meningioma. Brain Pathol. https://doi.org/10.1111/bpa.13132

4. Jiménez-Lara AM, Rey JA, Josefa Bello M, de Campos JM, Vaquero J, Elena Kusak M et al (1992) Cytogenetics of human meningiomas: an analysis of 125 cases. Cancer Genet Cytogenet 63:174. https://doi.org/10.1016/0165-4608(92)90526-E

5. Kolles H, Niedermayer I, Schmitt Ch, Henn W, Feld R, Steudel WI et al (1995) Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/feulgen stainings, and cytogenetics. Acta neurochir 137:174–181. https://doi.org/10.1007/BF02187190